|Chemical name: Apixaban
Typical dosage: 5mg
Typical type: Tablet1
Eliquis® is a medication typically used for the prevention and/or treatment of blood clots. It is currently only available as brand name and is an oral tablet.
Eliquis is a prescription medication that contains the active ingredient Apixaban. It is an oral medication taken twice daily for prevention or treatment of blood clots in patients with or without atrial fibrillation.
Eliquis inhibits clotting factor Xa and inhibits platelet activation and fibrin clot formation.
The most common side effects of Eliquis include bleeding and bruising easily.
Yes! 99% of Medicare Advantage plans and Medicare Part D plans cover Eliquis.1
Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Eliquis.
Find Medicare Advantage plans with drug coverageCompare Plans
Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.
Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.
|Deductible stage||Typical copay stage|
|Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.
In the deductible stage, you’re responsible for the full cost of your prescription drugs.
Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.
|After you meet your Part D deductible, you enter the initial coverage period.
During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
|$42 – $511||$19 – $511|
While many patients can safely use Eliquis, it is not currently recommended for women who are pregnant or breastfeeding.
It is important to tell any doctor you visit that you are on a blood thinning medication, especially before any surgery, medical or dental procedure.
Your risk of bleeding may be increased if you are taking aspirin, nonsteroidal anti-inflammatory drugs (such as ibuprofen or naproxen) or warfarin, along with other prescription or over-the-counter drugs. Talk to your doctor about your medications before starting Eliquis.
If you take Eliquis, do not stop taking it without talking to a doctor. Stopping Eliquis inappropriately may increase the risk of stroke.
If you are taking Eliquis, call your doctor immediately if you experience unusual signs of bleeding. This includes bleeding that lasts a long time, severe bleeding, pink or red-colored urine, red or black stools and vomiting blood or a substance that looks similar to coffee grounds. Eliquis is not indicated for patients with artificial heart valves or have problems with abnormal bleeding.
This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.
Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.
Written by Hayden Gharibyar, Pharm.D.
Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.
1 GoodRx. Eliquis. Retrieved May 2019, from www.goodrx.com/eliquis.
2 Jacobson, Gretchen; et al. A Dozen Facts About Medicare Advantage. (Nov. 13, 2018). Kaiser Family Foundation. Retrieved from www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage.
MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.
Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
Medicare has neither reviewed nor endorsed this information.